Xtandi 40 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FSCD8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,043
Award facts
- Contract value 100% obligated
- $34,042.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $34,042.72 to DMS Pharmaceutical Group Inc. on January 15, 2026, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, specializing in distributing pharmaceutical products and medical consumables to federal agencies, particularly the Department of Defense. The delivery order was issued without a set-aside designation under a firm fixed-price contract structure, with an ultimate completion date of January 16, 2026, and will be performed at the vendor's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply recurring pharmaceutical needs to military healthcare facilities worldwide. The underlying IDC, awarded in November 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to deliver a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FSCD8?
SPE2DR26FSCD8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FSCD8 worth?
The government has obligated $34,043 on SPE2DR26FSCD8.
Is contract SPE2DR26FSCD8 an order under another contract?
Yes. SPE2DR26FSCD8 is a delivery order under SPE2DR25D9316, an indefinite delivery contract.
Was contract SPE2DR26FSCD8 competed?
The extent of competition for SPE2DR26FSCD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award